Risk of all-cause and cardiovascular mortality in patients with chronic liver disease

Gut

Volumn 60, Issue 11, 2011, Pages 1602-1603

  Targher, Giovanni ^a   Zoppini, Giacomo ^a   Day, Christopher P ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC LIVER DISEASE; DEATH CERTIFICATE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEALTH SURVEY; HEPATITIS C; HUMAN; LETTER; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

FEMALE; HUMANS; LIVER DISEASES; MALE; METABOLIC SYNDROME X;

EID: 80053574709     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.230656     Document Type: Letter

References (4)

1. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010;59:1410-15.
2. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009;136:477-85.
3. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver. N Engl J Med 2010;363:1341-50.
4. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263-71.